- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x GLC- GLC: alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose(Non-covalent)
- 45 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 4 residues within 4Å:- Chain A: N.12, D.41, K.42
- Ligands: SO4.4
Ligand excluded by PLIPSO4.4: 7 residues within 4Å:- Chain A: K.42, N.150, Q.152, E.153, D.209, Y.210
- Ligands: SO4.3
Ligand excluded by PLIPSO4.5: 4 residues within 4Å:- Chain A: T.385, D.386, K.387, Q.470
Ligand excluded by PLIPSO4.6: 8 residues within 4Å:- Chain A: K.382, R.408, M.517
- Chain B: Y.99, N.100, I.333, P.334, Q.335
Ligand excluded by PLIPSO4.7: 2 residues within 4Å:- Chain A: Y.17, N.18
Ligand excluded by PLIPSO4.9: 8 residues within 4Å:- Chain A: Y.99, N.100, I.333, P.334, Q.335
- Chain B: K.382, R.408, M.517
Ligand excluded by PLIPSO4.10: 3 residues within 4Å:- Chain A: G.101
- Chain B: N.496, H.513
Ligand excluded by PLIPSO4.11: 6 residues within 4Å:- Chain A: D.379, N.496, H.512, H.513
- Chain B: G.101, K.102
Ligand excluded by PLIPSO4.12: 2 residues within 4Å:- Chain B: D.82, K.83
Ligand excluded by PLIPSO4.13: 3 residues within 4Å:- Chain B: P.40, D.41, K.46
Ligand excluded by PLIPSO4.14: 3 residues within 4Å:- Chain B: T.385, D.386, K.387
Ligand excluded by PLIPSO4.15: 2 residues within 4Å:- Chain B: Y.17, N.18
Ligand excluded by PLIPSO4.16: 2 residues within 4Å:- Chain B: T.356, D.358
Ligand excluded by PLIPSO4.17: 5 residues within 4Å:- Chain B: K.414, S.447, Y.466, K.468, Q.473
Ligand excluded by PLIPSO4.18: 4 residues within 4Å:- Chain B: G.13, E.214, N.234, K.297
Ligand excluded by PLIPSO4.21: 4 residues within 4Å:- Chain C: N.12, D.41, K.42
- Ligands: SO4.22
Ligand excluded by PLIPSO4.22: 7 residues within 4Å:- Chain C: K.42, N.150, Q.152, E.153, D.209, Y.210
- Ligands: SO4.21
Ligand excluded by PLIPSO4.23: 4 residues within 4Å:- Chain C: T.385, D.386, K.387, Q.470
Ligand excluded by PLIPSO4.24: 8 residues within 4Å:- Chain C: K.382, R.408, M.517
- Chain D: Y.99, N.100, I.333, P.334, Q.335
Ligand excluded by PLIPSO4.25: 2 residues within 4Å:- Chain C: Y.17, N.18
Ligand excluded by PLIPSO4.27: 8 residues within 4Å:- Chain C: Y.99, N.100, I.333, P.334, Q.335
- Chain D: K.382, R.408, M.517
Ligand excluded by PLIPSO4.28: 3 residues within 4Å:- Chain C: G.101
- Chain D: N.496, H.513
Ligand excluded by PLIPSO4.29: 6 residues within 4Å:- Chain C: D.379, N.496, H.512, H.513
- Chain D: G.101, K.102
Ligand excluded by PLIPSO4.30: 2 residues within 4Å:- Chain D: D.82, K.83
Ligand excluded by PLIPSO4.31: 3 residues within 4Å:- Chain D: P.40, D.41, K.46
Ligand excluded by PLIPSO4.32: 3 residues within 4Å:- Chain D: T.385, D.386, K.387
Ligand excluded by PLIPSO4.33: 2 residues within 4Å:- Chain D: Y.17, N.18
Ligand excluded by PLIPSO4.34: 2 residues within 4Å:- Chain D: T.356, D.358
Ligand excluded by PLIPSO4.35: 5 residues within 4Å:- Chain D: K.414, S.447, Y.466, K.468, Q.473
Ligand excluded by PLIPSO4.36: 4 residues within 4Å:- Chain D: G.13, E.214, N.234, K.297
Ligand excluded by PLIPSO4.39: 4 residues within 4Å:- Chain E: N.12, D.41, K.42
- Ligands: SO4.40
Ligand excluded by PLIPSO4.40: 7 residues within 4Å:- Chain E: K.42, N.150, Q.152, E.153, D.209, Y.210
- Ligands: SO4.39
Ligand excluded by PLIPSO4.41: 4 residues within 4Å:- Chain E: T.385, D.386, K.387, Q.470
Ligand excluded by PLIPSO4.42: 8 residues within 4Å:- Chain E: K.382, R.408, M.517
- Chain F: Y.99, N.100, I.333, P.334, Q.335
Ligand excluded by PLIPSO4.43: 2 residues within 4Å:- Chain E: Y.17, N.18
Ligand excluded by PLIPSO4.45: 8 residues within 4Å:- Chain E: Y.99, N.100, I.333, P.334, Q.335
- Chain F: K.382, R.408, M.517
Ligand excluded by PLIPSO4.46: 3 residues within 4Å:- Chain E: G.101
- Chain F: N.496, H.513
Ligand excluded by PLIPSO4.47: 6 residues within 4Å:- Chain E: D.379, N.496, H.512, H.513
- Chain F: G.101, K.102
Ligand excluded by PLIPSO4.48: 2 residues within 4Å:- Chain F: D.82, K.83
Ligand excluded by PLIPSO4.49: 3 residues within 4Å:- Chain F: P.40, D.41, K.46
Ligand excluded by PLIPSO4.50: 3 residues within 4Å:- Chain F: T.385, D.386, K.387
Ligand excluded by PLIPSO4.51: 2 residues within 4Å:- Chain F: Y.17, N.18
Ligand excluded by PLIPSO4.52: 2 residues within 4Å:- Chain F: T.356, D.358
Ligand excluded by PLIPSO4.53: 5 residues within 4Å:- Chain F: K.414, S.447, Y.466, K.468, Q.473
Ligand excluded by PLIPSO4.54: 4 residues within 4Å:- Chain F: G.13, E.214, N.234, K.297
Ligand excluded by PLIP- 3 x GOL: GLYCEROL(Non-functional Binders)
GOL.8: 6 residues within 4Å:- Chain A: F.443, H.472, Q.473, D.505, I.506, L.507
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:Q.471, A:Q.473, A:L.507
GOL.26: 6 residues within 4Å:- Chain C: F.443, H.472, Q.473, D.505, I.506, L.507
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:Q.471, C:Q.473, C:L.507
GOL.44: 6 residues within 4Å:- Chain E: F.443, H.472, Q.473, D.505, I.506, L.507
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:Q.471, E:Q.473, E:L.507
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jiang, J. et al., Structure of Tetrahymena telomerase reveals previously unknown subunits, functions, and interactions. Science (2015)
- Release Date
- 2015-10-28
- Peptides
- Maltose-binding periplasmic protein,Telomerase-associated protein 19: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x GLC- GLC: alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose(Non-covalent)
- 45 x SO4: SULFATE ION(Non-functional Binders)
- 3 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jiang, J. et al., Structure of Tetrahymena telomerase reveals previously unknown subunits, functions, and interactions. Science (2015)
- Release Date
- 2015-10-28
- Peptides
- Maltose-binding periplasmic protein,Telomerase-associated protein 19: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B